These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward. Terra SG; Johnson JA Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958 [TBL] [Abstract][Full Text] [Related]
3. Drug target pharmacogenomics: an overview. Johnson JA Am J Pharmacogenomics; 2001; 1(4):271-81. PubMed ID: 12083959 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics and drug response in cardiovascular disorders. Siest G; Jeannesson E; Berrahmoune H; Maumus S; Marteau JB; Mohr S; Visvikis S Pharmacogenomics; 2004 Oct; 5(7):779-802. PubMed ID: 15469403 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease. Dubé MP; de Denus S; Tardif JC Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy. Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice. Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005 [TBL] [Abstract][Full Text] [Related]
8. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics. Cresci S Expert Opin Pharmacother; 2005 Dec; 6(15):2577-91. PubMed ID: 16316298 [TBL] [Abstract][Full Text] [Related]
9. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics. Hoehe MR; Timmermann B; Lehrach H Curr Pharm Biotechnol; 2003 Dec; 4(6):351-78. PubMed ID: 14683431 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics, pharmacogenomics, and individualized medicine. Ma Q; Lu AY Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice. Shahabi P; Dubé MP Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics: the genetics of variable drug responses. Roden DM; Wilke RA; Kroemer HK; Stein CM Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584 [No Abstract] [Full Text] [Related]
13. Pharmacogenetics, pharmacogenomics and airway disease. Hall IP Respir Res; 2002; 3(1):10. PubMed ID: 11806845 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics? Roden DM Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics in drug development. McCarthy AD; Kennedy JL; Middleton LT Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107 [TBL] [Abstract][Full Text] [Related]
19. Engineering genomics. RNA antagonists--a new class of antisense drugs. Orum H IEEE Eng Med Biol Mag; 2005; 24(4):81-7. PubMed ID: 16119218 [No Abstract] [Full Text] [Related]
20. Human gene therapy and imaging: cardiology. Wu JC; Yla-Herttuala S Eur J Nucl Med Mol Imaging; 2005 Dec; 32 Suppl 2():S346-57. PubMed ID: 16096829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]